Concepedia

Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis

Gregory C McDermott, Michael DiIorio, Yumeko Kawano, Mary Jeffway, M G MacVicar, Kumar Dahal, Su‐Jin Moon, Thany Seyok, Jonathan S. Coblyn, Elena Massarotti,

Seminars in Arthritis and Rheumatism · 2024 · 10 citations · 20 references

DOIFull text

Open access

Concepts

References

20

EULAR definition of difficult-to-treat rheumatoid arthritis

György Nagy, Nadia M T Roodenrijs, Paco M J Welsing et al. · Annals of the Rheumatic Diseases · 2020 · 539 citations · Full text

, , +12

Extracting principal diagnosis, co-morbidity and smoking status for asthma research: evaluation of a natural language processing system

Qing Zeng, Sergey Goryachev, Scott T. Weiss et al. · BMC Medical Informatics and Decision Making · 2006 · 379 citations · Full text

, , +17

Electronic medical records for discovery research in rheumatoid arthritis

Katherine P. Liao, Tianxi Cai, Vivian S. Gainer et al. · Arthritis Care & Research · 2010 · 347 citations · Full text

, , +17

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann et al. · Nature Medicine · 2022 · 279 citations · Full text

, , +17

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

György Nagy, Nadia M T Roodenrijs, Paco M J Welsing et al. · Annals of the Rheumatic Diseases · 2021 · 276 citations · Full text

, , +7